Journal Title：Thoracic Cancer

Thoracic Cancer aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung cancer, esophageal cancer, mediastinal cancer, breast cancer and other thoracic malignancies. Prevention, treatment and research relevant to Asia-Pacific is a focus area, but submissions from all regions are welcomed. The editors encourage contributions relevant to prevention, general thoracic surgery, medical oncology, radiology, radiation medicine, pathology, basic cancer research, as well as epidemiological and translational studies in thoracic cancer. Thoracic Cancer is the official publication of the Chinese Society of Lung Cancer, International Chinese Society of Thoracic Surgery and is endorsed by the Korean Association for the Study of Lung Cancer and the Hong Kong Cancer Therapy Society.

The Journal publishes a range of article types including: Editorials, Invited Reviews, Mini Reviews, Original Articles, Clinical Guidelines, Technological Notes, Imaging in thoracic cancer, Meeting Reports, Case Reports, Letters to the Editor, Commentaries, and Brief Reports.

《胸腔癌》旨在促進肺癌、食道癌、縱隔癌、乳腺癌和其他胸部惡性腫瘤的基礎、轉化和應用臨床研究方面的國際合作和全面前沿信息的交流。亞太地區(qū)的預防、治療和研究是重點領域，但歡迎所有地區(qū)的投稿。編輯鼓勵投稿涉及預防、普通胸外科、腫瘤內科、放射學、放射醫(yī)學、病理學、基礎癌癥研究以及胸腔癌的流行病學和轉化研究。 《胸部腫瘤》是中華醫(yī)學會肺癌分會、國際華人胸外科學會的官方刊物，并得到韓國肺癌研究協會和香港癌癥治療學會的認可。

該期刊發(fā)表多種類型的文章，包括：社論、特邀評論、迷你評論、原創(chuàng)文章、臨床指南、技術說明、胸部腫瘤影像、會議報告、病例報告、致編輯的信、評論和簡要報告。

Thoracic Cancer創(chuàng)刊于2010年，由Blackwell Publishing Asia Pty Ltd出版商出版，收稿方向涵蓋ONCOLOGY - RESPIRATORY SYSTEM全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約2月 ，影響因子指數2.3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。